Consort item and number | Latin America (%) | Spain (%) | All (%) | ||
---|---|---|---|---|---|
Title & abstract | 1a | Title | 16 | 30 | 24 |
1b | Abstract | 55 | 82 | 70 | |
Methods | 3a | Trial design | 58 | 55 | 56 |
4a | Participants | 72 | 82 | 78 | |
4b | Settings | 43 | 44 | 43 | |
5 | Interventions | 88 | 84 | 86 | |
6a | Outcomes | 21 | 22 | 22 | |
Randomisation | 7a | Sample size | 22 | 19 | 20 |
8a | Sequence generation | 28 | 35 | 32 | |
9 | Allocation concealment | 12 | 11 | 11 | |
10 | Implementation | 3 | 0 | 1 | |
11a | Blinding | 24 | 18 | 21 | |
12a | Statistical methods | 44 | 37 | 40 | |
Results | 13a | Participant flow | 35 | 28 | 31 |
13b | Losses & exclusions | 20 | 19 | 19 | |
14a | Dates of recruitment | 5 | 4 | 4 | |
15 | Baseline data | 29 | 39 | 34 | |
16 | Numbers analysed | 15 | 15 | 15 | |
17a | Outcomes & estimation | 3 | 5 | 4 | |
19 | Harms | 26 | 29 | 28 | |
Other information | 23 | Registration | 2 | 5 | 4 |
24 | Protocol | 0 | 1 | 1 | |
25 | Funding | 28 | 25 | 26 |